• Return to Headlines

Arrowhead Pharma Has Returned 33.1% Since SmarTrend Recommendation (ARWR)

By Shiri Gupta

SmarTrend identified an Uptrend for Arrowhead Pharma (NASDAQ:ARWR) on January 8th, 2019 at $14.17. In approximately 2 months, Arrowhead Pharma has returned 33.07% as of today's recent price of $18.85.

Over the past year, Arrowhead Pharma has traded in a range of $6.26 to $22.39 and is now at $18.85, 201% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.9% while the 50-day MA has advanced 2.9%.

Arrowhead Pharmaceuticals, Inc. operates as a biotechnology company. The Company develops medicines that treat intractable diseases by silencing the genes. Arrowhead Pharmaceuticals offers its services in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Arrowhead Pharma shares.

Log in and add Arrowhead Pharma (ARWR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights arrowhead pharma

Ticker(s): ARWR